Table 3.

Outcomes for each centre, adjusted for demographics (age and gender) and co‐morbidity features (months on haemodialysis and Charlson index)

Outcomes	Weight	Adjusted rates					Comparison
	(%)	C1	C2	C3	C4	C5	LRd	P‐value
Evidence‐based clinical performance criteria	43
Kt/v ≥ 1.4	7	72.91	84.16	56.73a	85.61	86.70	10.79	0.003
Hb 11‐13 g/dlc	7	56.80	56.80	56.80	56.80	56.80	0.00	1.000
Ca 8.4–10 mg/dlc	3.5	81.70	81.70	81.70	81.70	81.70	0.00	1.000
P 2.5‐4.5 mg/dl	3.5	46.96	46.83	45.47	51.12	45.86	0.23	0.762
Functioning AAVF	15	57.07	73.16	71.18	75.73	73.62	2.66	0.184
Non‐hospitalization rate (1 year)b	7	56.82	54.56	59.63	65.90	65.93	1.09	0.438
Mortality	27
Cumulative survival (2 years)	27	78.40	70.60	74.20	86.80	83.70	0.58	0.596
Health related quality of life (HRQoL)	17
MCS from SF‐36 Meanc	8.5	49.65	49.65	49.65	49.65	49.65	2.82	0.169
PCS from SF‐36 Meanc	8.5	33.85	33.85	33.85	33.85	33.85	0.00	1.000
Patient satisfaction	13
DCQ Mean	13	91.24	94.54a	89.15	88.22	87.85	5.41	0.043
Patient Benefit (PB)		66.25	67.61	65.97	72.59	71.28
Cost (€ per patient per year)		42 574	39 289	32 872	35 461	35 294
Direct cost		34 247	31 044	22 174	26 497	26 350
Allocated cost		8 327	8 246	10 698	8 964	8 945
Value (PB/cost) × 10 000		15.56	17.21	20.07	20.47	20.20

^a P < 0.05.

^bValues were converted to positive values (100‐value), which reflect the non‐hospitalization rates.

^cEstimate for the random effect with variance equal to zero.

^dLR: Likelihood ratio test for models with and without random effects.

AAVF, Autologous arteriovenous fistula; Ca, Serum calcium; DCQ, Quality of Care in Dialysis Centre Questionnaire; Hb, Haemoglobin concentration; Kt/v, Dialysis adequacy calculated with the single pool Daugirdas II method; MCS, Mental component summary from SF‐36 Questionnaire; P, Serum phosphorous; PCS, Physical component summary from SF‐36 Questionnaire.